SynthesisInternational urology and nephrology2025
Prevalence of BK virus and BK virus-associated hemorrhagic cystitis in stem cell transplant recipients: a systematic review and meta-analysis.
Synthesis in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe BK virus (BKV) commonly affects stem cell transplant (SCT) patients and can lead to hemorrhagic cystitis (HC), a serious condition that negatively impacts patient health. This study reviews the frequency of BKV infections in SCT patients, particularly those who develop HC.
methodsWe searched Web of Science, PubMed, and Embase up to August 10, 2024, to identify relevant articles focusing on the prevalence of BKV-related hemorrhagic cystitis (HC) in stem cell transplant (SCT) patients. Two reviewers independently screened and extracted data using Nested Knowledge software. A meta-analysis of pooled prevalence rates was conducted using random-effects models in R software, version 4.4. Study heterogeneity was assessed with the I
resultsOf the 2700 articles identified, 15 met our inclusion criteria, encompassing 7856 participants. The overall pooled prevalence of BKV-related hemorrhagic cystitis (HC) was 12.8% (95% CI 8.7-18.5%), with rates varying significantly from 5.0 to 45.9%. This variation reflects differences in patient backgrounds, transplant methods, and diagnostic approaches (I
conclusionsOur study identified a substantial prevalence of BKV-associated hemorrhagic cystitis in stem cell transplant patients, highlighting the importance of vigilant monitoring and effective treatment strategies to manage this risk. Enhancing both diagnostic techniques and treatment approaches is crucial for improving patient outcomes.
Indexed as
Identifiers
40208448What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.